Streetbeat News

Assets

TMO

Investors have shown a bullish stance on Thermo Fisher Scientific (NYSE:TMO) through significant options trading, with a mix of 76% bullish and 23% bearish sentiment among large-scale trades. The trading activity suggests a target price range of $450 to $590 for TMO in the next three months. The largest options trades include both bearish and bullish positions, with a notable interest in puts. Thermo Fisher Scientific's current market status shows a trading volume of 1,194,108 and a price decrease of -1.63%, with an RSI indicating a potential oversold condition. Analysts have set an average price target of $623.33, with ratings ranging from Outperform to Neutral.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:31 pm

FCX

Over the past 5 years, Freeport-McMoRan (NYSE:FCX) has outperformed the market with an annualized return of 16.45%, averaging 28.43% annually. A $1000 investment in FCX 5 years ago would now be worth $3,613.59. The company's current market capitalization stands at $70.97 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:30 pm

MPW

Medical Properties Trust's shares are trading higher following the announcement of the sale of its majority interest in Utah Hospitals.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 8:28 pm

GLD

SPY

USO

Stocks declined due to uncertainty over potential rate cuts, while oil prices rose amid tensions in the Middle East, and gold prices continued to increase. The SPDR S&P 500 ETF Trust (SPY), United States Oil Fund (USO), and SPDR Gold Shares (GLD) are directly mentioned in relation to these market movements.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 8:12 pm

QMCO

Quantum Corporation (NASDAQ:QMCO) provided a business update including a Q4 2024 liquidity update, revealing $26.1M in cash and equivalents, $87.9M in term loan debt, and $26.6M in revolving credit borrowings. The company also reported a $4.1M interest expense for Q4. Quantum announced a transaction post-Q4, selling service inventory assets for $15M to pay down $12.3M in debt, aiming to improve financial flexibility. Additionally, Quantum completed a new ERP system implementation, expected to reduce capital expenditures and increase operational efficiencies. Quantum is working to avoid Nasdaq delisting, with a hearing scheduled for May 14, 2024. Marc E. Rothman will retire from the board by August 31, 2024, or the 2024 annual meeting date, with a search for a new director underway.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 8:10 pm

PLTR

Palantir Technologies Inc. (NYSE:PLTR) shares are trading lower amid market weakness and concerns over prolonged high interest rates by the Federal Reserve. Despite this, Palantir received positive remarks from Jim Cramer on CNBC and additional investment from Ark Invest. The stock is trading below its 50-day moving average and its 52-week high. A long-term forecast suggests a potential annualized stock performance continuation at 19.18%, aiming for a stock price of $54.20 in the future.

Portfolio Pulse from Erica Kollmann

April 12, 2024 | 8:09 pm

BTCUSD

Jonathan Wu, a venture capital investor, highlights the career benefits of switching to the crypto industry, citing less competition, faster career acceleration, and unique opportunities. His views sparked a debate on the risks and rewards of working in crypto, with several industry professionals sharing their success stories and emphasizing the sector's potential for growth and innovation.

Portfolio Pulse from Ivan Crnogatić

April 12, 2024 | 8:08 pm

MPW

Medical Properties Trust, Inc. (MPW) has sold a majority interest in five Utah hospitals to a joint venture, retaining a 25% interest. The deal, valued at $886 million for a 75% stake, affirms MPT's lease base of $1.2 billion and generates $1.1 billion in cash proceeds for MPT. This transaction, along with others, brings MPT's total liquidity transactions for the year to $1.6 billion, 80% of its FY 2024 target. Proceeds will be used to reduce debt and for general corporate purposes. MPT's underwriting approach is validated by this transaction, and the company is on track to exceed its $2 billion liquidity transaction target for 2024.

Portfolio Pulse from Benzinga Newsdesk

April 12, 2024 | 8:07 pm

FICO

Over the past 10 years, Fair Isaac (NYSE:FICO) has outperformed the market with an annualized return of 25.61%, averaging 36.22% annually. A $100 investment in FICO a decade ago would now be worth $2,248.47, showcasing the impact of compounded returns on investment growth. Fair Isaac's current market capitalization stands at $29.62 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:00 pm

CSGP

Over the past 20 years, CoStar Gr (NASDAQ:CSGP) has produced an average annual return of 17.07%, outperforming the market by 9.18% annually. A $1000 investment in CSGP 20 years ago would now be worth $23,437.82. CoStar Gr currently has a market capitalization of $36.95 billion.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 8:00 pm